Outcomes of the novolimus-eluting bioresorbable vascular scaffold in real world clinical practice
{{output}}
Background: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from everolimus-eluting stent platforms. Adverse events with the everolimus-eluting BRSs which are the most comprehensively characterize... ...
